FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leiv Ose

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Marit S Nenseter; Leiv Ose; Kjetil Retterstøl; Ingunn Narverud; Pål Aukrust; Martin P Bogsrud; Asgeir Græsdal; Bente Halvorsen; Kirsten B Holven
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
Ingunn Narverud; Marit S Nenseter; Leiv Ose; Kjetil Retterstøl; Per Morten Sandset; Thor Ueland; Stine M Ulven; Pål Aukrust; Bente Halvorsen; Per Ole Iversen; Siril G Johansen; Kirsten B Holven
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH.
Marit S Nenseter; Leiv Ose; Ingunn Narverud; Pål Aukrust; Martin P Bogsrud; Asgeir Græsdal; Bente Halvorsen; Kirsten B Holven
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leiv Ose (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marit S Nenseter; Leiv Ose; Kjetil Retterstøl; Ingunn Narverud; Pål Aukrust; Martin P Bogsrud; Asgeir Græsdal; Bente Halvorsen; Kirsten B Holven
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
Journal of clinical lipidology 2013;7(2):109-16.
2013: Ingunn Narverud; Marit S Nenseter; Leiv Ose; Kjetil Retterstøl; Per Morten Sandset; Thor Ueland; Stine M Ulven; Pål Aukrust; Bente Halvorsen; Per Ole Iversen; Siril G Johansen; Kirsten B Holven
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH.
Thrombosis research 2013;131(2):178-82.
2013: Marit S Nenseter; Leiv Ose; Ingunn Narverud; Pål Aukrust; Martin P Bogsrud; Asgeir Græsdal; Bente Halvorsen; Kirsten B Holven
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.
Cytokine 2013;61(1):194-8.
2013: I Narverud; Marit S Nenseter; O K Olstad; Leiv Ose; Kjetil Retterstøl; Stine M Ulven; Arne Yndestad; T B Dahl; Bente Halvorsen; Kirsten B Holven; Pål Aukrust
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia.
Journal of internal medicine 2013;273(1):69-78.
2012: Marit S Nenseter; Leiv Ose; Ingunn Narverud; Pål Aukrust; Martin P Bogsrud; Asgeir Græsdal; Bente Halvorsen; Kirsten B Holven
LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia.
Thrombosis research 2012;130(5):823-5.
2012: D M Kusters; Leiv Ose; K Widhalm; N Bratina; C de Beaufort; O Guardamagna; Albert Wiegman
Paediatric screening for hypercholesterolaemia in Europe.
Archives of disease in childhood 2012;97(3):272-6.
2011: Marit S Nenseter; Leiv Ose; Kirsten B Holven; Gisle Langslet; Henriette Walaas Lindvig; Thor Ueland; Kjetil Retterstøl
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.
Atherosclerosis 2011;216(2):426-32.
2011: Arne Svilaas; EC Strøm; Siril G Johansen; Guri Vebenstad; Tone Svilaas; Leiv Ose
[Assessment of dietary habits and life style].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2011;131(5):454.
2011: Ingunn Narverud; Thor Ueland; Marit S Nenseter; Kjetil Retterstøl; Vibeke H Telle-Hansen; Bente Halvorsen; Leiv Ose; Pål Aukrust; Kirsten B Holven
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10.
Atherosclerosis 2011;214(1):163-8.
2010: Gisle Langslet; Inger Ottestad; Kjetil Retterstøl; Leiv Ose
[Clinical trials--viewpoints from participants].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2010;130(16):1606-8.
2010: Martin Prøven Bogsrud; Leiv Ose; Gisle Langslet; Inger Ottestad; Ellen Charlotte Strøm; Tor-Arne Hagve; Kjetil Retterstøl
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study.
Scandinavian cardiovascular journal : SCJ 2010;44(4):197-200.
2010: Leiv Ose; Dragos Budinski; Neil Hounslow; Valerie Arneson
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia.
Atherosclerosis 2010;210(1):202-8.
2009: Kari Anne R Tobin; Kirsten B Holven; Kjetil Retterstøl; Ellen Strøm; Leiv Ose; Pål Aukrust; Marit S Nenseter
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins.
The British journal of nutrition 2009;102(12):1783-9.
2009: Leiv Ose; Dragos Budinski; Neil Hounslow; Valerie Arneson
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia.
Current medical research and opinion 2009;25(11):2755-64.
2009: Marijn C Meuwese; Eric de Groot; Raphaël Duivenvoorden; Mieke D Trip; Leiv Ose; Frans J Maritz; Dick C G Basart; John J P Kastelein; Rafik Habib; Michael H Davidson; Aeilko H Zwinderman; Lee R Schwocho; Evan A Stein
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
JAMA : the journal of the American Medical Association 2009;301(11):1131-9.
2009: Marit S Nenseter; Thor Ueland; Kjetil Retterstøl; Ellen Strøm; Lars Mørkrid; Sverre Landaas; Leiv Ose; Pål Aukrust; Kirsten B Holven
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins.
Stroke; a journal of cerebral circulation 2009;40(1):241-7.
2009: Janette Khoury; Agot L Amundsen; Serena Tonstad; Tore Henriksen; Leiv Ose; Kjetil Retterstøl; Per Ole Iversen
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia.
Acta obstetricia et gynecologica Scandinavica 2009;88(2):222-6.
2008: Kirsten B Holven; Pål Aukrust; Kjetil Retterstøl; Kari Otterdal; Vigdis Bjerkeli; Leiv Ose; Marit S Nenseter; Bente Halvorsen
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.
The Journal of nutrition 2008;138(11):2070-5.
2008: Leiv Ose
The real code of leonardo da vinci.
Current cardiology reviews 2008;4(1):60-2.
2008: Trond P Leren; Tora Himle Finborud; Turid Manshaus; Leiv Ose; Knut Erik Berge
Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
Community genetics 2008;11(1):26-35.
2007: Leiv Ose; Robert Reyes; Amy O Johnson-Levonas; Aditi Sapre; Diane L Tribble; Thomas Musliner
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Clinical therapeutics 2007;29(11):2419-32.
2007: Trond P Leren; Turid Manshaus; Leiv Ose; Knut Erik Berge
[Lipid profile in children and adolescents with familial hypercholesterolemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2007;127(18):2363-6.
2007: Serena Tonstad; Kjetil Retterstøl; Leiv Ose; K Peter Ohman; Magnus B Lindberg; Maria Svensson
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
Metabolism: clinical and experimental 2007;56(9):1285-92.
2007: Leiv Ose; Amy O Johnson-Levonas; Robert Reyes; J Lin; A Shah; Diane L Tribble; Thomas Musliner
A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet.
International journal of clinical practice 2007;61(9):1469-80.
2007: Theodore Feldman; Leiv Ose; Arvind Shah; Michelle Zakson; Alan Meehan; Amy O Johnson-Levonas; Darbie Maccubbin; Diane L Tribble; Enrico Veltri; Yale B Mitchel
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome.
Metabolic syndrome and related disorders 2007;5(1):13-21.
2007: Kirsten B Holven; Pål Aukrust; T M Pedersen; Leiv Ose; Marit S Nenseter
Enhanced platelet activation in hyperhomocysteinemic individuals.
Journal of thrombosis and haemostasis : JTH 2007;5(1):193-5.
2007: Agot Lia Amundsen; Janette Khoury; Per Morten Sandset; Ingebjørg Seljeflot; Leiv Ose; Serena Tonstad; Tore Henriksen; Kjetil Retterstøl; Per Ole Iversen
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia.
Thrombosis research 2007;120(1):21-7.
2006: Agot Lia Amundsen; Janette Khoury; Per Ole Iversen; Caroline Bergei; Leiv Ose; Serena Tonstad; Kjetil Retterstøl
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia.
Atherosclerosis 2006;189(2):451-7.
2006: Kirsten B Holven; Bente Halvorsen; Vigdis Bjerkeli; Jan Kristian Damås; Kjetil Retterstøl; Lars Mørkrid; Leiv Ose; Pål Aukrust; Marit S Nenseter
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects.
Stroke; a journal of cerebral circulation 2006;37(7):1731-6.
2006: Monica Hermann; Martin P Bogsrud; Espen Molden; Anders Asberg; Beata U Mohebi; Leiv Ose; Kjetil Retterstøl
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.
Clinical pharmacology and therapeutics 2006;79(6):532-9.
2006: Jan C Frich; Leiv Ose; Kirsti Malterud; Per Fugelli
Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study.
Annals of family medicine 2006;4(3):198-204.
2006: Leiv Ose; Arvind Shah; Michael J Davies; Jennifer Rotonda; Darbie Maccubbin; Diane L Tribble; Enrico Veltri; Yale B Mitchel
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Current medical research and opinion 2006;22(5):823-35.
2006: Knut Erik Berge; Leiv Ose; Trond P Leren
Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(5):1094-100.
2006: Inger O Ottestad; Bente Halvorsen; Trude R Balstad; Kari Otterdal; Grethe Iren A Borge; Frank Brosstad; Anne M Myhre; Leiv Ose; Marit S Nenseter; Kirsten B Holven
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux.
The Journal of nutrition 2006;136(4):877-81.
2006: Thor Ueland; Maud N Vissers; Albert Wiegman; Jessica Rodenburg; Barbara A Hutten; Lars Gullestad; Leiv Ose; N Rifai; P M Ridker; J J P Kastelein; Pål Aukrust; Anne G Semb
Increased inflammatory markers in children with familial hypercholesterolaemia.
European journal of clinical investigation 2006;36(3):147-52.
2006: Leiv Ose; Finn Egil Skjeldestad; Inger Johanne Bakken; Andree Levorsen; Evo Alemao; Don D Yin; Fredrik Borgström; Linus Jönsson
Lipid management and cholesterol goal attainment in Norway.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(2):121-8.
2006: Kirsten B Holven; Pål Aukrust; K Retterstol; Tor-Arne Hagve; Lars Mørkrid; Leiv Ose; Marit S Nenseter
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects.
Scandinavian journal of clinical and laboratory investigation 2006;66(1):45-54.
2006: Kirsten B Holven; Jan Kristian Damås; Arne Yndestad; Torgun Waehre; Thor Ueland; Bente Halvorsen; Lars Heggelund; Wiggo J Sandberg; Anne G Semb; Stig S Frøland; Leiv Ose; Marit S Nenseter; Pål Aukrust
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(1):200-5.
2005: T R Balstad; Kirsten B Holven; I O Ottestad; Kari Otterdal; Bente Halvorsen; Anne M Myhre; Leiv Ose; Marit S Nenseter
Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function.
Clinica chimica acta; international journal of clinical chemistry 2005;359(1-2):171-8.
2004: Agot Lia Amundsen; Fady Y Ntanios; N van der Put; Leiv Ose
Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread.
European journal of clinical nutrition 2004;58(12):1612-20.
2004: Harold E Bays; Leiv Ose; Neil Fraser; Diane L Tribble; Katherine Quinto; Robert Reyes; Amy O Johnson-Levonas; Aditi Sapre; Steven R Donahue
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Clinical therapeutics 2004;26(11):1758-73.
2004: Trond P Leren; Turid Manshaus; Leiv Ose
[A family-based strategy for diagnosing familial hypercholesterolemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(9):1228-9.
2004: Arne Svilaas; Amrit Kaur Sakhi; Lene Frost Andersen; Tone Svilaas; Ellen C Ström; David R Jacobs; Leiv Ose; Rune Blomhoff
Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans.
The Journal of nutrition 2004;134(3):562-7.
2004: Leiv Ose
Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children.
Seminars in vascular medicine 2004;4(1):51-7.
2004: S Blomhoff; Kirsten B Holven; Frank Brosstad; Leiv Ose; Marit S Nenseter
Psychological factors and cardiovascular disease.
Journal of thrombosis and haemostasis : JTH 2004;2(1):201-3.
2003: Michael H Davidson; Leiv Ose; Jiri Frohlich; Russell S Scott; Carlos A Dujovne; Ivan D Escobar; Marcelo C Bertolami; Frank Cihon; Darbie Maccubbin; Michele Mercuri
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
Clinical cardiology 2003;26(11):509-14.
2003: Kirsten B Holven; Hanne Scholz; Bente Halvorsen; Pål Aukrust; Leiv Ose; Marit S Nenseter
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells.
The Journal of nutrition 2003;133(11):3588-91.
2003: Kirsten B Holven; Anne M Myhre; Pål Aukrust; Tor-Arne Hagve; Leiv Ose; Marit S Nenseter
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender.
European heart journal 2003;24(19):1756-62.
2003: Brian W McCrindle; Leiv Ose; A David Marais
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
The Journal of pediatrics 2003;143(1):74-80.
2003: Kirsten B Holven; Bente Halvorsen; H Schulz; Pål Aukrust; Leiv Ose; Marit S Nenseter
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects.
European journal of clinical investigation 2003;33(7):555-60.
2003: Atle Fretheim; Andrew D Oxman; Arild Bjørndal; Audun Dyrdal; Michael Golding; Leiv Ose; DzSmund Reikvam; Per Teisberg
[Shortcomings and strength of practice guidelines].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2003;123(11):1566-7.
2003: Kirsten B Holven; Tor S. Haugstad; Torbjørn Holm; Pål Aukrust; Leiv Ose; Marit S Nenseter
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects.
The British journal of nutrition 2003;89(3):359-63.
2002: Anders G Olsson; Helge Istad; Olavi Luurila; Leiv Ose; Steen Stender; Jaakko Tuomilehto; Olov Wiklund; Harry Southworth; John Pears; J W Wilpshaar
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.
American heart journal 2002;144(6):1044-51.
2002: Saskia de Jongh; Leiv Ose; Tamás Szamosi; Claude Gagné; M Lambert; Russell Scott; Patrice Perron; Dries Dobbelaere; M Saborio; Mary B Tuohy; Michael Stepanavage; Aditi Sapre; Barry Gumbiner; Michele Mercuri; A S Paul van Trotsenburg; Henk D Bakker; John J P Kastelein
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin.
Circulation 2002;106(17):2231-7.
2002: Atle Fretheim; Arild Bjørndal; Andrew D Oxman; Audun Dyrdal; Michael Golding; Leiv Ose; Asmund Reikvam; Per Teisberg
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(23):2287-8.
2002: Atle Fretheim; Arild Bjørndal; Andrew D Oxman; Audun Dyrdal; Michael Golding; Leiv Ose; Asmund Reikvam; Per Teisberg
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(23):2283-6.
2002: Atle Fretheim; Arild Bjørndal; Andrew D Oxman; Audun Dyrdal; Michael Golding; Leiv Ose; Asmund Reikvam; Per Teisberg
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(23):2277-81.
2002: Agot Lia Amundsen; Leiv Ose; Marit S Nenseter; Fady Y Ntanios
Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia.
The American journal of clinical nutrition 2002;76(2):338-44.
2002: Leiv Ose
Familial hypercholesterolemia from children to adults.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(4):289-93.
2002: Leiv Ose
[Müller-Harbitz disease--familial hypercholesterolemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(9):924-5.
2002: Arne Svilaas; E C Ström; Tone Svilaas; A Borgejordet; Magne Thoresen; Leiv Ose
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2002;12(2):60-70.
2002: Kirsten B Holven; Pål Aukrust; Torbjørn Holm; Leiv Ose; Marit S Nenseter
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(4):699-703.
2001: Serena Tonstad; EC Strøm; Caroline Bergei; Leiv Ose; B Christophersen
Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2001;11(5):320-6.
2001: Trond P Leren; S Tonstad; Leiv Ose
[Genetic screening and treatment in familial hypercholesterolemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(13):1635-6.
2001: Trond P Leren; S Tonstad; Leiv Ose
[Familial hypercholesterolemia--prognosis and treatment].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(13):1635.
2001: Kirsten B Holven; Torbjørn Holm; Pål Aukrust; B Christensen; J Kjekshus; A K Andreassen; L Gullestad; Tor-Arne Hagve; Arne Svilaas; Leiv Ose; Marit S Nenseter
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects.
The American journal of medicine 2001;110(7):536-42.
2001: Arne Svilaas; Leiv Ose; K Risberg; Magne Thoresen
[Treatment goals for blood lipids in high risk patients of atherosclerotic disease].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(9):1059-63.
2000: Marit S Nenseter; B Østerud; T Larsen; EC Strøm; Caroline Bergei; S Hewitt; Kirsten B Holven; Tor-Arne Hagve; S A Mjøs; M Solvang; J Pettersen; J Opstvedt; Leiv Ose
Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2000;10(6):323-30.
2000: S Tonstad; Oddmund Joakimsen; Trond P Leren; Leiv Ose
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?
Acta paediatrica (Oslo, Norway : 1992) 2000;89(12):1490-2.
2000: Arne Svilaas; K Risberg; Magne Thoresen; Leiv Ose
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice.
The American journal of cardiology 2000;86(11):1250-3, A6.
2000: Michael H Davidson; Evan A Stein; Donald B Hunninghake; Leiv Ose; Carlos A Dujovne; William Insull; Marcelo C Bertolami; Stuart R Weiss; John J P Kastelein; Russell S Scott; S Campodónico; Ivan D Escobar; Helmut Schrott; Harold E Bays; Michael Stepanavage; M Wu; A C Tate; MR Melino; Debra Kush; Michele Mercuri; Yale B Mitchel
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2000;10(5):253-62.
2000: Arne Svilaas; Caroline Bergei; EC Strøm; Leiv Ose; H K Walsøe
[The diet of patients with atherosclerotic disease compared with the standard diet in the population].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2000;120(22):2618-24.
2000: John J P Kastelein; Jonathan L Isaacsohn; Leiv Ose; Donald B Hunninghake; J Frohlich; Michael H Davidson; R Habib; Carlos A Dujovne; John R Crouse; M Liu; MR Melino; L O'Grady; Michele Mercuri; Yale B Mitchel
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
The American journal of cardiology 2000;86(2):221-3.
2000: Trond P Leren; Leiv Ose; Anders Hamsten; Fredrik Karpe
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1784-8.
2000: Arne Svilaas; H K Walsöe; Leiv Ose
Application of simple lipid treatment goals in patients with atherosclerotic disease.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2000;10(2):71-8.
2000: Leiv Ose; Olavi Luurila; J Eriksson; A Olsson; H Lithell; B Widgren
Cerivastatin gender effect: sub-analyses of results from a multinational, randomised, double-blind study. Cerivastatin Study Group.
Current medical research and opinion 2000;16(2):80-7.
2000: Leiv Ose; Michael H Davidson; Evan A Stein; John J P Kastelein; Russell S Scott; Donald B Hunninghake; S Campodonico; William Insull; Ivan D Escobar; Helmut Schrott; Michael Stepanavage; M Wu; A C Tate; MR Melino; Michele Mercuri; Yale B Mitchel
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
Clinical cardiology 2000;23(1):39-46.
1999: Leiv Ose
An update on familial hypercholesterolaemia.
Annals of medicine 1999;31 Suppl 1():13-8.
1999: OK Rødningen; S Tonstad; Jheem D Medh; DA Chappell; Leiv Ose; Trond P Leren
Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene.
Journal of lipid research 1999;40(2):213-20.
1999: Leiv Ose; Olavi Luurila; J Eriksson; A Olsson; H Lithell; B Widgren
Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group.
Current medical research and opinion 1999;15(3):228-40.
1999: OK Rødningen; S Tonstad; Ola Didrik Saugstad; Leiv Ose; Trond P Leren
Mutant transcripts of the LDL receptor gene: mRNA structure and quantity.
Human mutation 1999;13(3):186-96.
1998: S Tonstad; Oddmund Joakimsen; Eva Stensland-Bugge; Leiv Ose; Kaare H Bønaa; Trond P Leren
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects.
European journal of clinical investigation 1998;28(12):971-9.
1998: Jean Davignon; M Hanefeld; N Nakaya; Donald B Hunninghake; William Insull; Leiv Ose
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
The American journal of cardiology 1998;82(4B):32J-39J.
1998: Leiv Ose; L E Vollebaek; Serena Tonstad
[Attitude to genetic screening for familial hypercholesterolemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(10):1578-81.
1998: E Sundt; Leiv Ose; S Tonstad
[Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1998;118(5):749-52.
1998: Serena Tonstad; H Refsum; Leiv Ose; Per Magne Ueland
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine.
The Journal of pediatrics 1998;132(2):365-8.
1998: OK Rødningen; S Tonstad; Leiv Ose; Kåre Berg; Trond P Leren
Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA.
Human mutation 1998;12(2):95-102.
1997: S Tonstad; Trond P Leren; Leiv Ose
[Diagnosis and treatment of severe hyperlipidemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(29):4241-4.
1997: Arne Svilaas; P Bye; EC Strøm; O Kolbjørnsen; Serena Tonstad; Leiv Ose
[What happens with patients after participation in a clinical trial?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(28):4065-9.
1997: P Urdal; Trond P Leren; S Tonstad; P K Lund; Leiv Ose
Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia.
Cytometry 1997;30(5):264-8.
1997: Trond P Leren; S Tonstad; K E Gundersen; Kari Solberg Bakken; OK Rødningen; H Sundvold; Leiv Ose; Kåre Berg
Molecular genetics of familial hypercholesterolaemia in Norway.
Journal of internal medicine 1997;241(3):185-94.
1997: Trond P Leren; Leiv Ose
[Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(5):681-3.
1997: Trond P Leren; Kari Solberg Bakken; OK Rødningen; K E Gundersen; H Sundvold; Kåre Berg; S Tonstad; Leiv Ose
[Application of gene technology in the diagnosis of familial hypercholesterolemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(5):678-81.
1997: Trond P Leren; Kari Solberg Bakken; U Daum; Leiv Ose; Kåre Berg; Gerd Assmann; Arnold von Eckardstein
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
Journal of lipid research 1997;38(1):121-31.
1996: K Retterstøl; M Stugaard; C Gørbitz; Leiv Ose
Results of intensive long-term treatment of familial hypercholesterolemia.
The American journal of cardiology 1996;78(12):1369-74.
1996: S Tonstad; E Sundt; Leiv Ose; T A Hagve; J C Fruchart; J M Bard; S Edén
The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia.
Metabolism: clinical and experimental 1996;45(11):1415-21.
1996: S Tonstad; Oddmund Joakimsen; Eva Stensland-Bugge; T P Leren; Leiv Ose; D Russell; Kaare H Bønaa
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(8):984-91.
1996: S Tonstad; H Refsum; M Sivertsen; B Christophersen; Leiv Ose; Per Magne Ueland
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives.
Pediatric research 1996;40(1):47-52.
1996: S Tonstad; J Knudtzon; M Sivertsen; H Refsum; Leiv Ose
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia.
The Journal of pediatrics 1996;129(1):42-9.
1996: K E Gundersen; K Solberg; OK Rødningen; S Tonstad; Leiv Ose; Kåre Berg; Trond P Leren
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia.
Clinical genetics 1996;49(2):85-7.
1996: S Tonstad; M Sivertsen; L Aksnes; Leiv Ose
Low dose colestipol in adolescents with familial hypercholesterolaemia.
Archives of disease in childhood 1996;74(2):157-60.
1996: H Sundvold; K Solberg; S Tonstad; OK Rødningen; Leiv Ose; Kåre Berg; Trond P Leren
A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects.
Human mutation 1996;7(1):70-1.
1995: Leiv Ose
[Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1995;115(29):3629-31.
1995: S Tonstad; L E Vollebaek; Leiv Ose
Screening for familial hypercholesterolaemia in relatives.
Lancet 1995;346(8987):1438.
1995: Leiv Ose; S Tonstad
The detection and management of dyslipidaemia in children and adolescents.
Acta paediatrica (Oslo, Norway : 1992) 1995;84(11):1213-5.
1995: Trond P Leren; K Solberg; OK Rødningen; S Tonstad; Leiv Ose
Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia.
Human genetics 1995;96(2):241-2.
1995: S Tonstad; T P Leren; M Sivertsen; Leiv Ose
Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(8):1009-14.
1995: K Løhne; P Urdal; Trond P Leren; S Tonstad; Leiv Ose
Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells.
Cytometry 1995;20(4):290-5.
1995: S Tonstad; Leiv Ose; C Gørbitz; O Djøseland; J M Bard; J C Fruchart
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women.
Journal of internal medicine 1995;238(1):39-47.
1995: Trond P Leren; H Sundvold; OK Rødningen; S Tonstad; K Solberg; Leiv Ose; Kåre Berg
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia.
Human genetics 1995;95(6):671-6.
1995: Trond P Leren; OK Rødningen; S Tonstad; O Røsby; P Urdal; Leiv Ose
Identification of the apo B-3500 mutation in the Norwegian population.
Scandinavian journal of clinical and laboratory investigation 1995;55(3):217-21.
1995: C Gørbitz; C S Bergei; M Sivertsen; Leiv Ose; T Abyholm
[Diet and lipid status in pregnant women].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1995;115(11):1358-60.
1995: S Tonstad; Hallvard Holdaas; C Gørbitz; Leiv Ose
Is dietary intervention effective in post-transplant hyperlipidaemia?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(1):82-5.
1994: Trond P Leren; K Solberg; OK Rødningen; S Tonstad; Leiv Ose
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects.
Atherosclerosis 1994;111(2):175-82.
1994: K Solberg; OK Rødningen; S Tonstad; Leiv Ose; Trond P Leren
Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene.
Scandinavian journal of clinical and laboratory investigation 1994;54(8):605-9.
1994: S Tonstad; C Gørbitz; Leiv Ose; U F Malt
[A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(19):2262-4.
1994: C Gørbitz; Leiv Ose
[Diet therapy of hypercholesterolemia. Can the diet of persons who already follow a cholesterol-lowering diet be further improved by guidelines given by a clinical nutritionist?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(18):2106-8.
1994: C Gørbitz; Leiv Ose
[Iron status in postmenopausal women].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(4):436-8.
1994: E Hagen; H Istad; Leiv Ose; E Bodd; H M Eriksen; V Selvig; J M Bard; J C Fruchart; M Borge; M C Wolf
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
European journal of clinical pharmacology 1994;46(5):445-9.
1993: Trond P Leren; K Solberg; OK Rødningen; Leiv Ose; S Tonstad; Kåre Berg
Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene.
PCR methods and applications 1993;3(3):159-62.
1993: OK Rødningen; Trond P Leren; O Røsby; S Tonstad; Leiv Ose; Kåre Berg
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects.
Clinical genetics 1993;44(4):214-20.
1993: K Solberg; OK Rødningen; S Tonstad; Leiv Ose; Kåre Berg; Trond P Leren
Short report on DNA marker at candidate locus.
Clinical genetics 1993;44(2):111.
1993: S Tonstad; Leiv Ose; C Gørbitz; E M Harrison; H J de Koning Gans
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia.
Scandinavian journal of clinical and laboratory investigation 1993;53(5):457-63.
1993: Trond P Leren; K Solberg; OK Rødningen; O Røsby; S Tonstad; Leiv Ose; Kåre Berg
Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop.
Human genetics 1993;92(1):6-10.
1992: OK Rødningen; O Røsby; S Tonstad; Leiv Ose; Kåre Berg; Trond P Leren
A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects.
Clinical genetics 1992;42(6):288-95.
1992: Trond P Leren; K Solberg; O Røsby; OK Rødningen; S Tonstad; Leiv Ose; Kåre Berg
A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects.
Clinical genetics 1992;42(5):224-8.
1992: M Stugaard; I Wiig; H Lund; Leiv Ose; J Norseth
[Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(20):2642-6.
1992: K Purvis; A Tollefsrud; H Rui; E Haug; J Norseth; L Viksmoen; Leiv Ose; H Lund
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia.
European journal of clinical pharmacology 1992;42(1):61-4.
1991: S Graff-Iversen; H A Holm; H Istad; Leiv Ose; A K Rom; I S Kristiansen; D Thelle; H Torsvik; P Urdal; J Wiik
[Treatment of hypercholesterolemia in adults. A treatment program 1991].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1991;111(28):3407-11.
1991: M Grønn; C Gørbitz; E Christensen; Andree Levorsen; Leiv Ose; Tor-Arne Hagve; Bjørn O Christophersen
Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study.
Scandinavian journal of clinical and laboratory investigation 1991;51(3):255-63.
1991: P M Sandset; H Lund; J Norseth; U Abildgaard; Leiv Ose
Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(1):138-45.
1989: Leiv Ose; J P Blomhoff; H Torsvik
[Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1989;109(7-8):850-2.
1989: Leiv Ose; M Grønn; Andree Levorsen; O Trygstad; H Lund; I Wiig
Dietary n-3 fatty acids and children with hyperlipidaemia.
Journal of internal medicine. Supplement 1989;731():181-3.